Basal-Bolus Insulin Therapy

---

ONLINE

Friday, September 13, 2024, 12:00 AM - Sunday, September 12, 2027, 11:59 PM


AMA PRA Category 1 Credits™ (1.00 hours), AAPA Category 1 CME (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

Achieving adequate glycemic control in patients, both with and without diabetes, is a crucial component of comprehensive cancer care. Hyperglycemia during hospitalization is linked to a heightened risk of complications and prolonged hospital stays. This educational module aims to introduce basal-bolus insulin (BBI) therapy as the standard treatment for inpatient hyperglycemia. The module covers the essential principles of BBI therapy, including its components, the benefits of BBI over sliding scale insulin (SSI), and collaborative care strategies for managing hyperglycemia in hospitalized patients.

1. Identify the advantages of basal-bolus insulin therapy over sliding scale insulin.
2. Demonstrate proficiency in utilizing the insulin decision support tool.
3. Identify how to use the insulin decision support tool.
4. Summarize the collaborative care strategies in the prevention and management of hyperglycemia.

Participants may access and complete the course in the online Education Center (Taleo Learn). There is no registration fee for this educational activity.


RELEASE DATE: SEPTEMBER 6, 2024
EXPIRATION DATE: SEPTEMBER 5, 2027
Estimated time to complete:  60 minutes

Content: 
Please click on the Education Center link to be re-directed to the Education Center and prompted to login. 
Once logged in, enter 'Basal-Bolus' in the search bar to locate the activities. 

Education Center

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation: 

The University of Texas MD Anderson Cancer Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this enduring material will award 1.00 Nursing Contact Hours.

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until September 5, 2027. PAs should only claim credit commensurate with the extent of their participation.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.